D. Ogreid

发表

The effect of ligands of phenylalanine 4-monooxygenase on the cAMP-dependent phosphorylation of the enzyme.

T. Flatmark, D. Øgreid, S. Døskeland, 1984, The Journal of biological chemistry.

Mutations that alter the charge of type I regulatory subunit and modify activation properties of cyclic AMP-dependent protein kinase from S49 mouse lymphoma cells.

I. Weber, S. Døskeland, S. Døskeland, 1991, The Journal of biological chemistry.

Derivatives of 1-beta-D-ribofuranosylbenzimidazole 3',5'-phosphate that mimic the actions of adenosine 3',5'-phosphate (cAMP) and guanosine 3',5'-phosphate (cGMP).

S. Døskeland, B. Jastorff, R. Störmann, 1992, Carbohydrate research.

Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil.

H. Sorbye, L. Balteskard, P. Pfeiffer, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk.

L. Harries, D. Øgreid, D. Phillips, 1997, Carcinogenesis.

The separate estimation of cAMP intracellularly bound to the regulatory subunits of protein kinase I and II in glucagon-stimulated rat hepatocytes.

S. Døskeland, T. Christoffersen, D. Ogreid, 1985, The Journal of biological chemistry.

[Medical education in Norway. One common education, four different models].

P. Brodal, V. Fønnebø, G. Bovim, 1997, Tidsskrift for Den Norske Laegeforening.

Phase II study of short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) in patients with progressive colorectal cancer after irinotecan and 5-fluorouracil (FU) treatment

H. Sorbye, B. Glimelius, P. Pfeiffer, 2004 .

[Determination of the activated proto-oncogene (Ki-ras) in feces. A new laboratory analysis for early diagnosis of colorectal cancer].

O. Røkke, J. Koornstra, K. Haug, 1995, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

The expression of cAMP-dependent protein kinase subunits is differentially regulated during liver regeneration.

E. Krebs, S. Døskeland, J. Scott, 1989, The Journal of biological chemistry.

Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinase.

D. Øgreid, S. Døskeland, J. Corbin, 1986, The Journal of biological chemistry.

Comparison of the two classes of binding sites (A and B) of type I and type II cyclic-AMP-dependent protein kinases by using cyclic nucleotide analogs.

S. Døskeland, D. Ogreid, J. Miller, 1989, European journal of biochemistry.

(Rp)- and (Sp)-8-piperidino-adenosine 3',5'-(cyclic)thiophosphates discriminate completely between site A and B of the regulatory subunits of cAMP-dependent protein kinase type I and II.

S. Døskeland, B. Jastorff, H. Genieser, 1994, European journal of biochemistry.

Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates.

Susan S. Taylor, S. Taylor, D. Øgreid, 1990, The Journal of biological chemistry.

Binding proteins for cyclic AMP in mammalian tissues.

D. Øgreid, S. Døskeland, D. Ogreid, 1981, The International journal of biochemistry.

Ammonium sulfate precipitation assay for the study of cyclic nucleotide binding to proteins.

S. Døskeland, D. Ogreid, 1988, Methods in enzymology.

Mapping of the two intrachain cyclic nucleotide binding sites of adenosine cyclic 3',5'-phosphate dependent protein kinase I.

S. Døskeland, D. Ogreid, J. Miller, 1983, Biochemistry.

Studies on the interactions between the cyclic nucleotide-binding sites of cGMP-dependent protein kinase.

S. Døskeland, O. Vintermyr, J. Corbin, 1987, The Journal of biological chemistry.

Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3',5'-cyclic monophosphate provides a biological means for control of human colon cancer cell growth.

G. Merlo, S. Døskeland, G. Tortora, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination. Principles for optimizing the isozyme specificity of analog combinations.

D. Øgreid, S. Døskeland, J. Corbin, 1985, European journal of biochemistry.

Characterization of cyclic adenosine 3':5'-monophosphate-dependent protein kinase isozymes in normal and neoplastic fetal rat brain cells.

S. Døskeland, O. Vintermyr, O. Laerum, 1985, Cancer research.

Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder.

D. Ogreid, L. Daehlin, G. Olderøy, 1998, Anticancer research.

Cyclic nucleotides modulate the release of [3H] adenosine cyclic 3',5'-phosphate bound to the regulatory moiety of protein kinase I by the catalytic subunit of the kinase.

S. Døskeland, D. Ogreid, 1983, Biochemistry.

Evidence that cyclic nucleotides activating rabbit muscle protein kinase I interact with both types of cAMP binding sites associated with the enzyme.

S. Døskeland, D. Ogreid, J. Miller, 1983, The Journal of biological chemistry.